1. Home
  2. OMH vs MRKR Comparison

OMH vs MRKR Comparison

Compare OMH & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

N/A

Current Price

$1.37

Market Cap

28.7M

Sector

Finance

ML Signal

N/A

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.26

Market Cap

23.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMH
MRKR
Founded
2015
N/A
Country
Singapore
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.7M
23.0M
IPO Year
2022
2010

Fundamental Metrics

Financial Performance
Metric
OMH
MRKR
Price
$1.37
$1.26
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
N/A
$11.25
AVG Volume (30 Days)
25.5K
116.7K
Earning Date
11-28-2025
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.61
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$28.40
N/A
Revenue Next Year
$23.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$0.81
52 Week High
$4.33
$4.07

Technical Indicators

Market Signals
Indicator
OMH
MRKR
Relative Strength Index (RSI) 52.67 40.49
Support Level $1.03 $0.83
Resistance Level $1.35 $1.44
Average True Range (ATR) 0.09 0.10
MACD 0.02 -0.00
Stochastic Oscillator 75.61 18.33

Price Performance

Historical Comparison
OMH
MRKR

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: